Nadroparina

ATC B01AB06 · 2 markets · 17 records

Nadroparina 2 markets · 17 records Forms
Filters
MarketFR 8

FR 8 records · 8 shown of 8 Source Base de données publique des médic · Data as of 2026-11-03

  • 19,000 IUinjectionFRAXODI 19 000 U.I. Axa/1 ml, solution injectable (S.C.) en seringue pré-remplie
  • 15,200 IUinjectionFRAXODI 15 200 U.I. Axa/0,8 ml, solution injectable (S.C.) en seringue pré-remplie
  • 11,400 IUinjectionFRAXODI 11 400 U.I. Axa/0,6 ml, solution injectable (S.C.) en seringue pré-remplie
  • 9,500 IUinjectionFRAXIPARINE 9 500 U.I. Axa/1 ml, solution injectable (S.C.) en seringue pré-remplie
  • 7,600 IUinjectionFRAXIPARINE 7 600 U.I. Axa/0,8 ml, solution injectable (S.C.) en seringue pré-remplie
  • 5,700 IUinjectionFRAXIPARINE 5 700 U.I. Axa/0,6 ml, solution injectable (S.C.) en seringue pré-remplie
  • 3,800 IUinjectionFRAXIPARINE 3 800 U.I. Axa/0,4 ml, solution injectable (S.C.) en seringue pré-remplie
  • 2,850 IUinjectionFRAXIPARINE 2 850 U.I. Axa/0,3 ml, solution injectable (S.C.) en seringue pré-remplie
The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.